Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside the increasingly prominent clinical trial environment of the country, evolution to becoming a value chain group of companies in clinical research and how she plans to lead the company into the global market by leveraging its unrivalled, holistic service offering.
One of the unique strengths of Turkey is the country’s patient population and the high prevalence of certain diseases.
